Fiducial Markers Market: By Product By Modality, By Application, By End User and Geography  

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Fiducial Markers Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product (Gold, Gold Combination, Polymer, Others) By Modality (CT/CBCT, MRI, Ultrasound, Radiotherapy), By Application (Prostate Cancer, Lung Cancer, Breast Cancer, Gastric Cancer, Other Cancers), By End User (Hospitals & Outpatient Facilities, Independent Radiotherapy Centers, Cancer Research Centers) and Region  

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Fiducial Markers Market size was valued at US$ 112.4 million in 2022 and is expected to grow at a CAGR of 4.7% from 2023-2029. The global market provides a detailed overview and that can be segmented by product, by modality, and by Application. By product, the Fiducial Markers market growth has been segmented into Gold, Gold Combination, Polymer, and Others. The Gold segment is likely to be the largest and fastest-growing segment in terms of product. The rise of this segment is mainly due to the superior stability and precise visibility of these products across numerous imaging sensory systems. Gold fiducial markers is also available in amalgamation with other metals, such as platinum, titanium, and nickel, for improved efficiency.

For instance, when mixed with titanium stripes, these markers improve the visibility in MRI photos. Based on Modality, the Fiducial Markers market is segmented into CT/CBCT, MRI, Ultrasound, and Radiotherapy. Among these, the CT/CBCT segment is expected to have the fastest-growing market during the forecast period 2022-2028. Low dose exposure, the comfort of integration with current radiotherapy instruments, and orthogonal imaging characteristics of CBCT is the primary factors attributing to the fiducial markers market growth. Based on the Application, the Fiducial Markers market is segmented into Prostate Cancer, Lung Cancer, Breast Cancer, Gastric Cancer, and Other Cancers. The Prostate Cancer segment is expected to have a significant share in 2021. Rising product acceptance in the treatment of prostate cancer is the major factor driving the growth of the segment. The lung cancer segment is anticipated to observe the fastest growth. Based on the end user, the Fiducial Markers market is segmented into Hospitals and outpatient facilities, Independent Radiotherapy Centers, and Cancer Research Centers. The Hospitals & Outpatient Facilities segment is expected to have a significant share in 2021.

Fiducial Markers Market Key Development:
  • In February 2021, GE Healthcare announced innovative oncology care solutions In August 2022, ZOZO launched a zozofit 3D body measurement system to transform fit technology using the fiducial marker.

summary download arrow Download Free Sample

Fiducial Markers Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

4.7%

Largest Market

North America

Fastest Growing Market

North America

Fiducial Markers Market Dynmaics

The rise in the prevalence of cancer across the world is anticipated to propel the market growth over the forecast years. Moreover, increased awareness about fiducial markers due to precise cancer diagnosis is burgeoning the market growth over the forecast years.

Fiducial Markers Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2022

US$ 112.4 million

Market CAGR

4.7%

By Product

  • Gold
  • Gold Combination
  • Polymer
  • Others

By Modality

  • CT/CBCT
  • MRI
  • Ultrasound
  • Radiotherapy

By Application

  • Prostate Cancer
  • Lung Cancer
  • Breast Cancer
  • Gastric Cancer
  • Other Cancers

By End User

  • Hospitals & Outpatient Facilities
  • Independent Radiotherapy Centers
  • Cancer Research Centers

Key Features of the Report

  • The fiducial markers market report provides granular level information about the market size, regional market share, historic market and forecast.
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup's details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

BiomarC Restore is a Lumpectomy Fiducial Marker designed to be implanted into the body to precisely mark tissue and behaves as a distinctive reference point during radiotherapy target localization and stereotactic body radiotherapy (SBRT).

In May 2022, C4 Imaging announced the first case of prostate cancer using the Nova™ marker - intended to maximize MRI usefulness to progress the precision of cancer treatment.

problems related with the implantation of products and side effects after the procedure as well as high costs related with fiducial markers and lack of skilled specialists

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Fiducial Markers Market Introduction 
2.1.Global Fiducial Markers Market  - Taxonomy
2.2.Global Fiducial Markers Market  - Definitions
2.2.1. By Product Type
2.2.2. By Modality
2.2.3. By Application
2.2.4. By End User
2.2.5. By Region
3.Global Fiducial Markers Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Fiducial Markers Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Fiducial Markers Market  By Product Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Gold
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Gold Combination
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Polymer
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Others
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6.Global Fiducial Markers Market  By Modality, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. CT/CBCT
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. MRI
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Ultrasound
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Radiotherapy
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7.Global Fiducial Markers Market  By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. Prostate Cancer
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Lung Cancer
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Breast Cancer
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Gastric Cancer
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Other Cancers
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8.Global Fiducial Markers Market  By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. Hospitals & Outpatient Facilities
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Independent Radiotherapy Centers
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Cancer Research Centers
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
9.Global Fiducial Markers Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10.North America Fiducial Markers Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Gold
10.1.2.Gold Combination
10.1.3.Polymer
10.1.4.Others
10.2.  Modality Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.CT/CBCT
10.2.2.MRI
10.2.3.Ultrasound
10.2.4.Radiotherapy
10.3.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Prostate Cancer
10.3.2.Lung Cancer
10.3.3.Breast Cancer
10.3.4.Gastric Cancer
10.3.5.Other Cancers
10.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Hospitals & Outpatient Facilities
10.4.2.Independent Radiotherapy Centers
10.4.3.Cancer Research Centers
10.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11.Europe Fiducial Markers Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Gold
11.1.2.Gold Combination
11.1.3.Polymer
11.1.4.Others
11.2.  Modality Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.CT/CBCT
11.2.2.MRI
11.2.3.Ultrasound
11.2.4.Radiotherapy
11.3.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Prostate Cancer
11.3.2.Lung Cancer
11.3.3.Breast Cancer
11.3.4.Gastric Cancer
11.3.5.Other Cancers
11.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Hospitals & Outpatient Facilities
11.4.2.Independent Radiotherapy Centers
11.4.3.Cancer Research Centers
11.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
12.Asia Pacific (APAC) Fiducial Markers Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Gold
12.1.2.Gold Combination
12.1.3.Polymer
12.1.4.Others
12.2.  Modality Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.CT/CBCT
12.2.2.MRI
12.2.3.Ultrasound
12.2.4.Radiotherapy
12.3.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Prostate Cancer
12.3.2.Lung Cancer
12.3.3.Breast Cancer
12.3.4.Gastric Cancer
12.3.5.Other Cancers
12.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Hospitals & Outpatient Facilities
12.4.2.Independent Radiotherapy Centers
12.4.3.Cancer Research Centers
12.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13.Middle East and Africa (MEA) Fiducial Markers Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
13.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Gold
13.1.2.Gold Combination
13.1.3.Polymer
13.1.4.Others
13.2.  Modality Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.CT/CBCT
13.2.2.MRI
13.2.3.Ultrasound
13.2.4.Radiotherapy
13.3.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Prostate Cancer
13.3.2.Lung Cancer
13.3.3.Breast Cancer
13.3.4.Gastric Cancer
13.3.5.Other Cancers
13.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Hospitals & Outpatient Facilities
13.4.2.Independent Radiotherapy Centers
13.4.3.Cancer Research Centers
13.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14.Latin America Fiducial Markers Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
14.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Gold
14.1.2.Gold Combination
14.1.3.Polymer
14.1.4.Others
14.2.  Modality Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.CT/CBCT
14.2.2.MRI
14.2.3.Ultrasound
14.2.4.Radiotherapy
14.3.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Prostate Cancer
14.3.2.Lung Cancer
14.3.3.Breast Cancer
14.3.4.Gastric Cancer
14.3.5.Other Cancers
14.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Hospitals & Outpatient Facilities
14.4.2.Independent Radiotherapy Centers
14.4.3.Cancer Research Centers
14.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.CIVCO Radiotherapy (USA)
15.2.2.IZI Medical Products (USA)
15.2.3.Boston Scientific Corporation (USA)
15.2.4.Naslund Medical AB (Sweden)
15.2.5.IBA (Belgium)
15.2.6.Best Medical International, Inc. (USA)
15.2.7.Carbon Medical Technologies (USA)
15.2.8.Eckert & Ziegler (Germany)
15.2.9.Innovative Oncology Solutions (USA)
15.2.10.Medtronic (Ireland)
15.2.11.QlRad Inc. (USA)
16. Research Methodology 
17. Appendix and Abbreviations 

Key Market Players

  • CIVCO Radiotherapy (USA)
  • IZI Medical Products (USA)
  • Boston Scientific Corporation (USA)
  • Naslund Medical AB (Sweden)
  • IBA (Belgium)
  • Best Medical International, Inc. (USA)
  • Nanovi A/S (Denmark)
  • Carbon Medical Technologies (USA)
  • Eckert & Ziegler (Germany)
  • Innovative Oncology Solutions (USA)
  • Medtronic (Ireland)
  • QlRad Inc. (USA)
  • JJ-Medtech (Netherlands)
  • QFIX (USA)

Related Industry Reports

Egypt Diabetes Devices Market

Lithuania Surgical Equipment Market

Antimicrobials Market

Cancer Therapy Market